About 5,965 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  1,581 results

Improving Shingles Vaccination Rates in Family Medicine.
The Journal of Family Practice; Luther JS

Aug 26th, 2021 - At the end of the activity, participants will be able to: • Characterize the burden of herpes zoster infections. • Recommend the recombinant zoster vaccine to patients in accordance with guidance from the Advisory Committee on Immunization Practic...

Diminishing the Risk of Herpes Zoster Recurrence.
Journal of the American Academy of Dermatology; Heymann WR

Sep 13th, 2021 - Diminishing the Risk of Herpes Zoster Recurrence.|2021|Heymann WR,|

Use of disease-modifying antirheumatic drugs and the subsequent risk of herpes zoster i...
Rheumatology (Oxford, England); Qian J, Lassere MN et. al.

Sep 12th, 2021 - To examine the association between DMARD use and subsequent risk of herpes zoster in a large, heterogeneous, and prospective population-based cohort. Using data from a cohort of adults (45 and Up Study) recruited between 2006 and 2009 and linked t...

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility...
Clinical Immunology (Orlando, Fla.); Iivo H, Saila L et. al.

Sep 12th, 2021 - Almost all patients with autoimmune polyendocrine syndrome type 1 (APS-1) have neutralizing antibodies against type 1 interferons (IFN), important mediators of antiviral defense. Recently, neutralizing anti-IFN antibodies were shown to be a risk f...

Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients w...
Annals of the Rheumatic Diseases; Friedman MA, Curtis JR et. al.

Sep 9th, 2021 - Patients with rheumatic diseases are at increased risk of infectious complications; vaccinations are a critical component of their care. Disease-modifying antirheumatic drugs may reduce the immunogenicity of common vaccines. We will review here av...

see more →

Guidelines  3 results

Interventional management of neuropathic pain: NeuPSIG recommendations.
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization ...
MMWR. Recommendations and Reports : Morbidity and Mortali... Harpaz R, Ortega-Sanchez IR et. al.

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

see more →

Drugs  476 results see all →

Clinicaltrials.gov  2 results

Study on Efficacy of Attenuated Zoster Vaccine, Live

Apr 6th, 2020 - Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes. Primary infection is manifested as varicella (chickenpox) , whereas reactivation of latent VZV results in a localized eruption known as herpes zoster. The i...

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Apr 17th, 2019 - Study Design single blind study, prospective, parallel group, intent to treat trial Experiment duration: 7 days 2 visits (days 0, and 7) Reduction of symptoms Adverse events evaluation

see more →

News  322 results

Pembrolizumab Improves PFS in Relapsed/Refractory Hodgkin Lymphoma

Dec 4th, 2020 - Jonathan Cheng, MD Pembrolizumab (Keytruda) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared with brentuximab vedotin (Adcetris) in adult patients with relapsed/refractory ...

Acute Non-PHN Complications of Herpes Zoster

Nov 25th, 2020 - Acute complications of herpes zoster (HZ) other than post-herpetic neuralgia (PHN) are relatively common, a new study suggests. Researchers conducted a cohort study of unvaccinated immunocompetent adults with incident HZ (n=178,964) and matched to...

Debate: After Methotrexate Failure, Is JAK Inhibitor or Biologic Next?

Nov 23rd, 2020 - What is the next step in treatment after a person with rheumatoid arthritis fails to adequately respond to methotrexate — a Janus kinase (JAK) inhibitor or a biologic? That was the focus of a lively debate at the virtual annual meeting of the Amer...

Upadacitinib Safety Similar to Other JAK Inhibitors for Rheumatoid Arthritis

Nov 13th, 2020 - (Reuters Health) - A once-daily 15 mg dose of upadacitinib for rheumatoid arthritis has similar rates of malignancies, serious infections, major adverse cardiovascular events, and venous thromboembolic events as other Janus kinase (JAK) inhibitors...

Shingrix Effective in Older Adults With Preexisting Immune-Mediated Disorders

Oct 6th, 2020 - The adjuvanted recombinant zoster vaccine Shingrix appears to be effective in older adults with autoimmune diseases who are not receiving treatment regimens that suppress the immune system, according to a post hoc analysis of patients in two clini...

see more →

Patient Education  2 results see all →